Cardiometabolic Health Congress

JULY 25, 2024

Practical, Future-Focused Education Cardiorenal and metabolic diseases, fueled by poor lifestyle choices and health conditions, lead to type 2 diabetes, cardiovascular disease, and chronic kidney disease. The robust conference agenda begins with FDA updates and advancements in cardiorenal metabolic care.

Education 98

Education Innovation Risk Factors Obesity 98

Cardiometabolic Health Congress

OCTOBER 25, 2024

Keynote speaker and atherosclerosis expert Peter Libby, MD , captivated the audience with an update on his research into inflammation and atherosclerosis. He discussed therapeutic options not only for treating atherosclerosis but also for preventing cardiovascular disease.

CME 64

CME Innovation Education Atherosclerosis 64

Cardiometabolic Health Congress

AUGUST 14, 2024

The focus will be on the intricate interplay between cardiorenal and metabolic conditions, such as type 2 diabetes, cardiovascular disease, and chronic kidney disease, driven by lifestyle and health factors. Aronne, MD Expert Perspectives on Initiating and Maintaining Insulin Therapy in Type 2 Diabetes Patients Jay H.

CME 72

CME Education Diabetes Innovation 72

Cardiometabolic Health Congress

AUGUST 8, 2024

Cardiometabolic risk encompasses a complex spectrum of interrelated conditions, including cardiovascular disease, type 2 diabetes, and metabolic syndrome. One promising strategy is the formation of creative partnerships between patients and their healthcare teams.

Education 59

Education Kidney Disease Cardiovascular Disease Diabetes 59

Cardiometabolic Health Congress

NOVEMBER 8, 2023

2023, the American Heart Association (AHA) issued a presidential advisory on the urgency of this systemic disorder involving heart disease, kidney disease, diabetes and obesity. In its advisory, the AHA stressed an interdisciplinary team approach emphasizing social determinants of health, shortcomings in current efforts, and knowledge gaps.

Certification 52

Certification Nursing Kidney Disease Education 52

Cardiometabolic Health Congress

AUGUST 23, 2024

Our expert faculty at CMHC delve into critical issues, offering insights on managing very low LDL-C, addressing concerns with statins and new-onset diabetes, and exploring the residual ASCVD risk beyond LDL-C, among other essential topics, in the CMHC Lipid Management Hub.

Dementia 52

Dementia Cholesterol Risk Factors CME 52